| HEMPAS Test | Hereditary Erythrocytic Multinuclearity with Positive Acidified Serum Test |
|---|---|
| EGOT | erythrocytic glutamic oxaloacetic transaminase |
| HEMPAS | hereditary erythrocytic multinuclearity with positive acidified serum |
| GnRH | Gonadotropin Releasing Hormone [HP 1898, 2034] = LHRH = Go... |
| RPI | Reticulocyte Production Index |
| EEF | exo-erythrocytic forms |
|---|---|
| (14)C | 14)CO production from |
| U-(14)C | 14)CO(2) production from |
| VCO(2) | CO(2) production |
| CCPR | Crypt cell production rate |
| erythrocytic | Pertaining to an erythrocyte. (05 Mar 2000) |
|---|---|
| erythrocytic series | The cells in the various stages of development in the red bone marrow leading to the formation of the erythrocyte, e.g., erythroblasts, normoblasts, erythrocytes. (05 Mar 2000) |
| pair production | <physics> The simultaneous production of an electron and a positron by an interaction of a photon or a fast charged particle with the electronic field of a nucleus or other particle. (16 Dec 1997) |
| primary production | Production of organic substances by photosynthesis, the quantity of material so produced per unit time. (09 Oct 1997) |
| production | The act or process of producing, bringing forth or making. (18 Nov 1997) |
| speech production measurement | Measurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody. (12 Dec 1998) |
| steroid production rate | The total quantity of a given steroid formed in the body, usually expressed as milligrams per day; represents the sum of the glandular secretion of the steroid and extraglandular formation of it from various steroid precursors. (05 Mar 2000) |
| implantation theory of the production of endometriosis | That, at the time of menstruation, cells of the uterine mucosa pass through the fallopian tubes and escape into the pelvic cavity where they implant themselves on the peritoneum. (05 Mar 2000) |
| orphan drug production | Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|